To assess NK cell involvement in the efficacy of anti-CTLA4 treatment against idMMR neuroblastoma tumors, we depleted NK cells in animals, then inoculated them with idMMR neuroblastoma cells and treated them with anti-CTLA4 or isotype control antibodies (Figure S7K). The gene discussed is CTLA4; the disease is neuroblastoma.